Joan Koerber-Walker and AZBio, Will Drug Pricing Kill a Rising Phoenix?
Vital Health Podcast
by Vital Health Podcast
1y ago
Joan Koerber-Walker is President and CEO of the Arizona Bioindustry Association (AZBio), supporting one of the top emerging biotech clusters in the United States. Trained as an economist and a biotech investor herself, Joan is no stranger to pricing discussions. As the Build Back Better debate reached a fever pitch, all eyes turned to Arizona given the bill’s focus on drug pricing and Senator Kyrsten Sinema’s known support of the Arizona Biotech Sector.  While Build Back Better is no more, the drug pricing debate is not going away anytime soon.  In this podcast we discuss how the dru ..read more
Visit website
John Murphy, is Build Back Better Bad for Biotech?
Vital Health Podcast
by Vital Health Podcast
1y ago
John Murphy is the Vice President of the Biotechnology Innovation Organization (BIO), the largest trade association in the world representing biotechnology companies. John’s role encompasses all legal issues impacting healthcare biotechnology and is an expert on topical issues such as intellectual property, drug pricing, and legislation in the biopharma sector. In this podcast we discuss the drug pricing proposals included in President Biden’s signature legislation, Build Back Better. While many in the general public feel that it’s only fair that Medicare start to negotiate drug pricing simil ..read more
Visit website
Miriam Sturkenboom & VAC4EU: Timing is everything
Vital Health Podcast
by Vital Health Podcast
1y ago
Call it serendipity, ‘luck’, or being at the right place at the right time, but Miriam Sturkenboom led the IMI’s project Advance, which built a pan-European safety monitoring network for vaccines. You can’t make it up, but the project ended in March of 2019. Six months later, the world was thrown into chaos with the Wuhan virus, and ADVANCE, rebranded VAC4EU, now finds itself at the centre of a tsunami of vaccine roll-outs and safety studies in Europe. In this podcast we discuss how VAC4EU is currently active in the study and development of vaccines in the fight against COVID-19. We look back ..read more
Visit website
NCATS’ Chris Austin - R&D from NIH, to Industry, through Approval
Vital Health Podcast
by Vital Health Podcast
1y ago
After nearly two decades at the NIH and almost 10 years as founding director of the National Center for Advancing Translational Sciences (NCATS), Christopher Austin is crossing over to the ‘dark side’, joining Boston-based Flagship Pioneering, the highly respected bioplatforms innovation company. He’s one of Biopharma’s true visionaries, with an expert’s knowledge at the highest levels of government funded NIH research, translational innovation, and industry commercialization. In this podcast, we touch on the litany of proposals emanating from the US congress including international reference ..read more
Visit website
About the NIH, Industry, and the R&D Ecosystem, with Richard Moscicki, PhRMA
Vital Health Podcast
by Vital Health Podcast
1y ago
Richard Moscicki is the Executive Vice President for Science and Regulatory Advocacy and the Chief Medical Officer at Pharmaceutical Research and Manufacturers of America (PhRMA). Previously he was the Deputy Center Director for Science Operations for the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) and the Chief Medical Officer at Genzyme Corporation. In this podcast, we discuss the U.S. R&D ecosystem and the vital roles that NIH and the private sector play in bringing new therapies to patients. Richard was previously at Massachusetts General H ..read more
Visit website
Jack Scannell on Big Pharma’s Big Drug Discovery Problem
Vital Health Podcast
by Vital Health Podcast
1y ago
Jack Scannell is one of the world’s leading pharmaceutical industry analysts, as well as one of its most visionary. Jack caused a case of global pharmaceutical R&D indigestion when, a decade ago, he identified in a groundbreaking Nature publication that, unlike in the semi-conductor industry, which had seen the doubling of its productivity every 10 years, the exact opposite was true for the biopharmaceutical sector, where productivity had instead halved in each successive decade. Jack Scannell investigates R&D productivity from both an economic and a scientific perspective, with a focu ..read more
Visit website
Is U.S. reference pricing a fatal shot for biotech?
Vital Health Podcast
by Vital Health Podcast
1y ago
Drug pricing is becoming a hot political issue in Washington DC, with polls showing widespread bipartisan support for congressional action to control the cost of new medicines broadly. While this is political red meat for the base, the reality is that price ceilings on medicines as they are proposed in US House Bill H.R. 3. will weigh heavily on the U.S. biotech sector and particularly on California, which has dominated the development of new cutting-edge medicines over the last decade. California and has been responsible for nearly 25% of new drug discoveries in that period, but with many sta ..read more
Visit website
KU Leuven Launches Health Innovation Fellowship
Vital Health Podcast
by Vital Health Podcast
1y ago
While not featured in Hollywood blockbuster films like some universities from the UK, Boston, or California, Belgium’s KU Leuven University has topped the Reuters ranking as Europe’s most innovative university for four of the last six years. This Belgian innovation engine boasts more than 135 spin-off companies and has a dominant focus on healthcare innovation. In this podcast we discuss the role that KU Leuven plays in Flanders with Professors Maarten De Vos and Inge De Prins, who introduce the latest effort to broaden the EU’s innovation capacity through their new initiative focused on heal ..read more
Visit website
Ivermectin, Dr Pierre Kory’s magic bullet to fight COVID-19
Vital Health Podcast
by Vital Health Podcast
1y ago
Over the course of the summer, there was a vital discovery that severe, late stage COVID-19 which had been considered a near fatal condition could be successfully treated with dexamethasone, a corticosteroid. One of the key clinicians behind that discovery was Dr Pierre Kory, the President of the Front-Line COVID-19 Critical Care Alliance (FLCCC). Today, corticosteroid is part of the standard COVID-19 pathway, in no small part due to the efforts of the FLCCC. Last month, Dr Kory again lit up the internet, giving a forceful testimony in front of the US Senate Homeland Security Committee, descr ..read more
Visit website
Ivor Cummins, “The Fat Emperor” Takes on COVID-19 Lockdowns
Vital Health Podcast
by Vital Health Podcast
1y ago
If you’ve ever found yourself researching COVID-19 on YouTube, it’s likely you’ve stumbled onto a well-spoken Irishman named Ivor Cummins dissecting the impact of the pandemic with detailed graphs and analysis. Before the COVID-19 era, Ivor, a biochemical engineer, had a large following as a presenter on facts about cardiovascular disease, diabetes, and obesity on his very popular website ‘The Fat Emperor.’ However, since the outbreak of SARS-CoV-2, he has trained his eye on the pandemic with a series of in-depth YouTube videos commenting on the response of public health experts and calling in ..read more
Visit website

Follow Vital Health Podcast on Feedspot

Continue with Google
OR